These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34164951)

  • 1. Industry Payments to Practicing US Rheumatologists, 2014-2019.
    Putman MS; Goldsher JE; Crowson CS; Duarte-García A
    Arthritis Rheumatol; 2021 Nov; 73(11):2138-2144. PubMed ID: 34164951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.
    Hartung DM; Johnston K; Cohen DM; Nguyen T; Deodhar A; Bourdette DN
    JAMA Netw Open; 2018 Jun; 1(2):e180482. PubMed ID: 30646086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Payments by Pharmaceutical Manufacturers and Prescribing Behavior in Rheumatology.
    Duarte-García A; Crowson CS; McCoy RG; Herrin J; Lam V; Putman MS; Ross JS; Matteson EL; Shah ND
    Mayo Clin Proc; 2022 Feb; 97(2):250-260. PubMed ID: 35120693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Industry-Dermatologist Financial Relationship: Insight From the Open Payment Data.
    Feng H; Wu P; Leger M
    JAMA Dermatol; 2016 Dec; 152(12):1307-1313. PubMed ID: 27706478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of Industry Payments to Radiation Oncologists in 2014 Using the Centers for Medicare and Medicaid Services Open Payments Database.
    Jairam V; Yu JB
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):19-26. PubMed ID: 26547386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research and Nonresearch Industry Payments to Nephrologists in the United States between 2014 and 2021.
    Murayama A; Kamamoto S; Kugo H; Saito H; Ozaki A
    J Am Soc Nephrol; 2023 Oct; 34(10):1709-1720. PubMed ID: 37488676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018.
    Nalleballe K; Sheng S; Li C; Mahashabde R; Annapureddy AR; Mudassar K; Pothineni K; Veerapaneni P; Harada Y; Chilkulwar A; Ranabothu S; Brown A; Kapoor N; Onteddu S
    Stroke; 2020 Apr; 51(4):1339-1343. PubMed ID: 32078482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and Disparities of Industry Payments to Radiologists (2016-2020).
    Khunte M; Zhong A; Wu X; Payabvash S; Gandhi D; Forman HP; Malhotra A
    Acad Radiol; 2023 Dec; 30(12):3056-3063. PubMed ID: 37210267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial Relationships Between Pharmaceutical Companies and Rheumatologists in Japan Between 2016 and 2019.
    Murayama A; Mamada H; Shigeta H; Yoshinaga T; Saito H; Yamashita E; Tanimoto T; Ozaki A
    J Clin Rheumatol; 2023 Apr; 29(3):118-125. PubMed ID: 36729793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial relationships between neurologists and industry: The 2015 Open Payments database.
    Ahlawat A; Narayanaswami P
    Neurology; 2019 May; 92(21):1006-1013. PubMed ID: 31110144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 9-Year Investigation of Healthcare Industry Payments to Pulmonologists in the United States.
    Murayama A; Kugo H; Saito Y; Saito H; Tanimoto T; Ozaki A
    Ann Am Thorac Soc; 2023 Sep; 20(9):1283-1292. PubMed ID: 36961514
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019.
    Tarras ES; Marshall DC; Rosenzweig K; Korenstein D; Chimonas S
    JAMA Oncol; 2021 Mar; 7(3):440-444. PubMed ID: 33377904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial relationships between neurologists and industry: The 2015 Open Payments database.
    Ahlawat A; Narayanaswami P
    Neurology; 2018 Jun; 90(23):1063-1070. PubMed ID: 29728521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide.
    Bandari J; Ayyash OM; Turner RM; Jacobs BL; Davies BJ
    Cancer; 2017 Nov; 123(22):4356-4362. PubMed ID: 28749536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association between Industry Payments and Brand-Name Prescriptions in Otolaryngologists.
    Morse E; Hanna J; Mehra S
    Otolaryngol Head Neck Surg; 2019 Oct; 161(4):605-612. PubMed ID: 31547772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial conflicts of interest in dentistry: how much money do providers receive from industry?
    Lee KC; Chuang SK
    Gen Dent; 2020; 68(1):56-60. PubMed ID: 31859664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Industry payments and physicians prescriptions: Effect of a payment restriction policy.
    Ansari B
    Soc Sci Med; 2021 Jun; 278():113942. PubMed ID: 33892242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide patterns in industry payments to academic vascular surgeons.
    Cheng T; Boelitz K; Rybin D; Menard MT; Kalish J; Siracuse JJ; Farber A; Jones DW
    J Vasc Surg; 2021 Feb; 73(2):675-681. PubMed ID: 32535153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Nonresearch Industry Payments to Otolaryngologists in 2014 and 2015.
    Pathak N; Fujiwara RJT; Mehra S
    Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1028-1034. PubMed ID: 29437524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.